These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 21707603

  • 1. The effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy.
    Miller F.
    Dev Med Child Neurol; 2011 Aug; 53(8):679-80. PubMed ID: 21707603
    [No Abstract] [Full Text] [Related]

  • 2. Intrathecal baclofen infusion for ambulant children with cerebral palsy.
    Brochard S, Remy-Neris O, Filipetti P, Bussel B.
    Pediatr Neurol; 2009 Apr; 40(4):265-70. PubMed ID: 19302938
    [Abstract] [Full Text] [Related]

  • 3. Intrathecal baclofen.
    Russman BS.
    Dev Med Child Neurol; 2010 Jul; 52(7):601-2. PubMed ID: 19832881
    [No Abstract] [Full Text] [Related]

  • 4. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy.
    Buonaguro V, Scelsa B, Curci D, Monforte S, Iuorno T, Motta F.
    Pediatr Neurol; 2005 Aug; 33(2):110-3. PubMed ID: 16087055
    [Abstract] [Full Text] [Related]

  • 5. Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy.
    Morton RE, Gray N, Vloeberghs M.
    Dev Med Child Neurol; 2011 Aug; 53(8):736-41. PubMed ID: 21707598
    [Abstract] [Full Text] [Related]

  • 6. Baclofen infusion for spastic cerebral palsy.
    Steinbok P, O'Donnnell M.
    Clin Neurosurg; 2000 Aug; 47():440-57. PubMed ID: 11197716
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial.
    Hoving MA, van Raak EP, Spincemaille GH, Palmans LJ, Becher JG, Vles JS, Dutch Study Group on Child Spasticity.
    Eur J Paediatr Neurol; 2009 May; 13(3):240-6. PubMed ID: 18595749
    [Abstract] [Full Text] [Related]

  • 8. Continuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge?
    Ramstad K, Jahnsen R, Lofterod B, Skjeldal OH.
    Acta Paediatr; 2010 Nov; 99(11):1661-5. PubMed ID: 19912148
    [Abstract] [Full Text] [Related]

  • 9. Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion.
    Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbott R, Ward JD, Bloom KK, Brooks WH, Madsen JR, McLaughlin JF, Nadell JM.
    Pediatr Neurol; 2004 Mar; 30(3):163-8. PubMed ID: 15033197
    [Abstract] [Full Text] [Related]

  • 10. Complex dosing schedules for continuous intrathecal baclofen infusion.
    Krach LE, Kriel RL, Nugent AC.
    Pediatr Neurol; 2007 Nov; 37(5):354-9. PubMed ID: 17950422
    [Abstract] [Full Text] [Related]

  • 11. Intrathecal baclofen in the management of spasticity due to cerebral palsy.
    Vloeberghs M, Keetley R, Morton R.
    Pediatr Rehabil; 2005 Nov; 8(3):172-9. PubMed ID: 16087551
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up on continuous intrathecal Baclofen therapy in non-ambulant children with intractable spastic Cerebral Palsy.
    Vles GF, Soudant DL, Hoving MA, Vermeulen RJ, Bonouvrié LA, van Oostenbrugge RJ, Vles JS.
    Eur J Paediatr Neurol; 2013 Nov; 17(6):639-44. PubMed ID: 23871360
    [Abstract] [Full Text] [Related]

  • 13. Baclofen toxicity in an 8-year-old with an intrathecal baclofen pump.
    Yeh RN, Nypaver MM, Deegan TJ, Ayyangar R.
    J Emerg Med; 2004 Feb; 26(2):163-7. PubMed ID: 14980337
    [Abstract] [Full Text] [Related]

  • 14. Intrathecal baclofen use in adults with cerebral palsy.
    Krach LE.
    Dev Med Child Neurol; 2009 Oct; 51 Suppl 4():106-12. PubMed ID: 19740217
    [Abstract] [Full Text] [Related]

  • 15. Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study.
    Krach LE, Kriel RL, Day SM, Strauss DJ.
    Dev Med Child Neurol; 2010 Jul; 52(7):672-6. PubMed ID: 19811519
    [Abstract] [Full Text] [Related]

  • 16. New approaches to managing spasticity in children with cerebral palsy.
    Im D, McDonald CM.
    West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
    [No Abstract] [Full Text] [Related]

  • 17. Intrathecal Baclofen Therapy-Practical Approach: Clinical Benefits and Complication Management.
    Winter G, Beni-Adani L, Ben-Pazi H.
    J Child Neurol; 2018 Oct; 33(11):734-741. PubMed ID: 30009656
    [Abstract] [Full Text] [Related]

  • 18. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy.
    Hoving MA, van Raak EP, Spincemaille GH, van Kranen-Mastenbroek VH, van Kleef M, Gorter JW, Vles JS, Dutch Study Group on Child Spasticity.
    Eur J Paediatr Neurol; 2009 May; 13(3):247-56. PubMed ID: 18590974
    [Abstract] [Full Text] [Related]

  • 19. The role of intrathecal baclofen in the management of primary and secondary dystonia in children.
    Woon K, Tsegaye M, Vloeberghs MH.
    Br J Neurosurg; 2007 Aug; 21(4):355-8. PubMed ID: 17676454
    [Abstract] [Full Text] [Related]

  • 20. The effect of continuous intrathecal baclofen therapy on ambulatory children with cerebral palsy.
    Pruszczynski B, Sees J, Hulbert R, Church C, Henley J, Niiler T, Miller F.
    J Pediatr Orthop B; 2018 May; 27(3):214-220. PubMed ID: 28379909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.